|
May 1
|
MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
|
|
Apr 30
|
MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases
|
|
Apr 29
|
MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung Disease
|
|
Apr 3
|
MannKind Repays Certain Debt Obligations
|
|
Apr 1
|
MannKind Corporation (NASDAQ:MNKD) down to US$1.2b market cap, but institutional owners may not be as affected after a year of 9.7% returns
|
|
Mar 29
|
Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?
|
|
Mar 26
|
MannKind Announces CFO Transition
|
|
Mar 25
|
Jim Cramer Says You Should Avoid These 11 Stocks
|
|
Mar 11
|
INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps
|
|
Mar 5
|
MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8
|
|
Mar 4
|
MannKind Corporation Announces Participation at Upcoming Conferences
|
|
Mar 3
|
Analysts Just Made A Meaningful Upgrade To Their MannKind Corporation (NASDAQ:MNKD) Forecasts
|
|
Jan 2
|
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
|
|
Dec 28
|
MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 3
|
Investors in MannKind (NASDAQ:MNKD) have seen solid returns of 115% over the past five years
|
|
Aug 28
|
12 Best High Risk Penny Stocks to Buy Now
|
|
Aug 22
|
When Will MannKind Corporation (NASDAQ:MNKD) Breakeven?
|